NIVAS News Hub

Do you have news you would like to share on the NIVAS News Hub?

If you have an RSS feed you wish to share with up please contact us here.

Showing 1-12 of 2223 results.

IVTEAM

Central venous access devices for neonates – Full Text

"Optimal CVAD selection is not merely a technical decision but a strategic clinical process that integrates patient, therapy, device, and health-system factors. Existing frameworks provide valuable guidance and should be interpreted within the clinical context in which they are applied, acknowledging differences in expertise, available resources, and models of care" de Souza et al (2026).

IVTEAM

Reducing peripheral intravenous catheter use in adult acute care – Full Text

"Despite growing awareness of inappropriate PIVC use, unnecessary insertion persists, driven by cultural and organisational norms and risk-averse practices. Interventions to reduce PIVC use have been implemented, but their effectiveness and sustainability have not been systematically synthesised" Barrington et al (2026).

IVTEAM

Neuromuscular blocking drug extravasation – Full Text

"This case highlights the unpredictable clinical course of NMBD extravasation and demonstrates that recurrent paralysis may occur despite initial successful reversal, requiring quantitative neuromuscular monitoring, extended postoperative observation, and administration of repeat doses of sugammadex as delayed systemic absorption occurs" Crafton et al (2026).

IVTEAM

PIVO Pro for avoiding blood culture contamination – Full Text

"Our primary objective is to compare the efficacy of the PIVO Pro at PIVC insertion for avoiding blood culture contamination to standard practice (typically specimen collection via venepuncture or a newly inserted PIVC)" Lovegrove et al (2026).

Vascular Access

Ultrasound measurement of skin-to-septum distance in totally implantable venous access ports: Considerations for Huber needle length

New publication on Ultrasound measurement of skin-to-septum distance in totally implantable venous access ports: Considerations for Huber needle length from the Journal of Vascular Access…

Continue reading → Ultrasound measurement of skin-to-septum distance in totally implantable venous access ports: Considerations for Huber needle length

IVTEAM

Continuous intravenous acyclovir during OPAT – Full Text

"The acyclovir OPAT programme led to cost savings of 3486 EUR per patient. Despite this small case series, continuous intravenous acyclovir appears to be feasible for treating HSV and VZV neurological infections in an OPAT setting, with potential benefits in patient comfort, healthcare costs, and hospital resource utilization" Manders et al (2026).

NIVAS Partners

The NIVAS Board

UK Vessel Health & Preservation Video